Onward Medical N.V.
ONWRF
$4.60
-$0.39-7.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 227.94% | -38.73% | -109.25% | -91.45% | -74.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 227.94% | -38.73% | -109.25% | -91.45% | -74.55% |
| Cost of Revenue | -9.37% | -12.41% | -15.34% | -3.45% | 7.44% |
| Gross Profit | 17.87% | 10.06% | 1.51% | -10.49% | -21.46% |
| SG&A Expenses | 13.96% | 7.85% | 1.88% | 10.38% | 17.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.67% | -1.17% | -3.90% | 3.06% | 8.28% |
| Operating Income | 1.72% | -0.21% | -2.30% | -8.99% | -13.82% |
| Income Before Tax | 0.82% | 0.87% | 0.83% | -5.80% | -10.53% |
| Income Tax Expenses | -136.91% | 51.82% | 63.81% | 89.48% | 114.94% |
| Earnings from Continuing Operations | 1.23% | 0.44% | -0.44% | -7.84% | -13.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.23% | 0.44% | -0.44% | -7.84% | -13.35% |
| EBIT | 1.72% | -0.21% | -2.30% | -8.99% | -13.82% |
| EBITDA | 2.22% | 0.26% | -1.92% | -8.84% | -13.98% |
| EPS Basic | 29.34% | 18.22% | 6.44% | -4.20% | -13.36% |
| Normalized Basic EPS | 28.80% | 18.45% | 7.68% | -2.17% | -10.55% |
| EPS Diluted | 29.17% | 18.11% | 6.39% | -4.08% | -13.06% |
| Normalized Diluted EPS | 28.80% | 18.45% | 7.68% | -2.17% | -10.55% |
| Average Basic Shares Outstanding | 47.86% | 27.71% | 7.55% | 3.77% | 0.00% |
| Average Diluted Shares Outstanding | 47.86% | 27.71% | 7.55% | 3.77% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |